Full Text View
Tabular View
No Study Results Posted
Related Studies
A Clinical Trial to Evaluate the Safety and Efficacy of Enjuvia 0.3 mg for the Treatment of Vulvovaginal Atrophy
This study has been completed.
Study NCT00196378   Information provided by Duramed Research
First Received: September 13, 2005   Last Updated: July 23, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Menopause
Additional conditions recognized in this trial
Atrophy
More general conditions related to this trial
Pathological Conditions, Anatomical
Interventions listed in this trial
Synthetic Conjugated estrogens, B
Placebo
Additional drug interventions recognized in this trial
Estrogens
Estrogens, Conjugated (USP)
Estrogens, conjugated synthetic B
More general drug interventions related to this trial
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Duramed Research


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services